Kymab's atopic dermatitis candidate well tolerated in Phase I

Kymab Group Ltd. (Cambridge, U.K.) said single and multiple

Read the full 94 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE